[Acute ischemia and heart failure during cyclic chemotherapy in a patient with plasmocytic myeloma].
Drzewoski
J
J
Pracowni Farmakologi Klinicznej Zakładu Farmakologii AM.
Olszańska-Skorek
T
T
Urbańska-Ryś
H
H
Kończalik
P
P
Krykowski
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002330:Carmustine / Q000008:administration & dosage; D003327:Coronary Disease / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000008:administration & dosage; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone
Ostre niedokrwienie i niewydolność serca w czasie cyklicznej chemioterapii u chorego na szpiczaka plazmocytowego.